Skip to main content
Erschienen in: International Urogynecology Journal 5/2006

01.10.2006 | Original Article

Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse

verfasst von: James Chivian Lukban, Oscar A. Aguirre, G. Willy Davila, Peter K. Sand

Erschienen in: International Urogynecology Journal | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Our objective was to determine the safety and effectiveness of Colpexin Sphere in women with advanced genital prolapse. A total of 39 subjects were enrolled in our prospective multicenter clinical trial, and 27 completed the full 16-week assessment. At baseline, subjects were fitted with a sphere, instructed on insertion and removal, and educated on a regimen of pelvic floor muscle exercises performed with the device in place. Efficacy was evaluated by a baseline vs 16-week comparison of pelvic organ prolapse staging and pelvic floor muscle strength assessment. Safety evaluation included, but was not limited to, an assessment of vaginal mucosal integrity. Subjects also completed a patient satisfaction questionnaire at the end of the study. Improvement in the prolapse of at least one vaginal segment was seen in 81.5% of the subjects, while 63% exhibited improved muscle function on digital examination at 16 weeks. Twenty-five (92.6%) would recommend the device to treat prolapse, and most found it easy to insert (96.3%) and remove (100%). In short-term usage, problems with urination (29.6%) and defecation (72%) were reported, primarily due to device displacement. Two subjects developed superficial vaginal mucosal ulceration, which resolved spontaneously. No significant adverse events were reported.
Literatur
1.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed
2.
Zurück zum Zitat Cundiff GW, Addison WA (1998) Management of pelvic organ prolapse. Obstet Gynecol Clin North Am 25:907–921CrossRefPubMed Cundiff GW, Addison WA (1998) Management of pelvic organ prolapse. Obstet Gynecol Clin North Am 25:907–921CrossRefPubMed
3.
Zurück zum Zitat Adamkiewicz MM, Adamkiewicz MF, Jozwik M, Jozwik M (2001) Combined treatment of pelvic floor exercises and new intravaginal device for genital prolapse. Int Urogynecol J 12(Suppl 3):S48 Adamkiewicz MM, Adamkiewicz MF, Jozwik M, Jozwik M (2001) Combined treatment of pelvic floor exercises and new intravaginal device for genital prolapse. Int Urogynecol J 12(Suppl 3):S48
4.
Zurück zum Zitat Baden WF, Walker T (1992) Fundamentals, symptoms, and classification. In: Baden WF, Walker T (eds) Surgical repair of vaginal defects. JB Lippincott, Philadelphia, p 14 Baden WF, Walker T (1992) Fundamentals, symptoms, and classification. In: Baden WF, Walker T (eds) Surgical repair of vaginal defects. JB Lippincott, Philadelphia, p 14
5.
Zurück zum Zitat Brink CA, Sampselle CM, Wells TJ, Diokno AC, Gillis GL (1989) A digital test for pelvic muscle strength in older women with urinary incontinence. Nurs Res 38:196–199PubMedCrossRef Brink CA, Sampselle CM, Wells TJ, Diokno AC, Gillis GL (1989) A digital test for pelvic muscle strength in older women with urinary incontinence. Nurs Res 38:196–199PubMedCrossRef
6.
Zurück zum Zitat Guerette N, Neimark M, Kopka SL, Jones JE, Davila GW (2004) Initial experience with a new method for the dynamic assessment of pelvic floor function in women. Int Urogynecol J Pelvic Floor Dysfunct 15:39–43CrossRefPubMed Guerette N, Neimark M, Kopka SL, Jones JE, Davila GW (2004) Initial experience with a new method for the dynamic assessment of pelvic floor function in women. Int Urogynecol J Pelvic Floor Dysfunct 15:39–43CrossRefPubMed
8.
Zurück zum Zitat Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL (2004) Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 190:1025–1029CrossRefPubMed Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL (2004) Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol 190:1025–1029CrossRefPubMed
9.
Zurück zum Zitat Wu V, Farrell SA, Baskett TF, Flowerdew G (1997) A simplified protocol for pessary management. Obstet Gynecol 90:990–994CrossRefPubMed Wu V, Farrell SA, Baskett TF, Flowerdew G (1997) A simplified protocol for pessary management. Obstet Gynecol 90:990–994CrossRefPubMed
10.
Zurück zum Zitat Handa VL, Jones M (2002) Do pessaries prevent the progression of pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct 13:349–352CrossRefPubMed Handa VL, Jones M (2002) Do pessaries prevent the progression of pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct 13:349–352CrossRefPubMed
Metadaten
Titel
Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse
verfasst von
James Chivian Lukban
Oscar A. Aguirre
G. Willy Davila
Peter K. Sand
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 5/2006
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-005-0033-2

Weitere Artikel der Ausgabe 5/2006

International Urogynecology Journal 5/2006 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.